Latest market headlines for HONASA on Terminal.
23-Oct-2026 12:17:34
Senior management change effective October 23, 2026; he will lead product, technology, engineering and analytics with a mandate to advance the company's AI-led…
05-Oct-2026 17:49:07
• Sequoia Capital Global Growth Fund III – U.S. / India Annex Fund L.P. sold 25,02,289 equity shares of face value ₹10 each of Honasa Consumer Limited. • The t…
25-Aug-2026 21:02:31
• Company has today called off the proposed acquisition of Fluence Pharma Private Limited • The acquisition was subject to completion of conditions precedent,…
07-Jul-2026 17:32:02
• Honasa Health Private Limited has been incorporated as a wholly owned subsidiary of the company on July 7, 2026. • The Certificate of Incorporation was recei…
26-Jun-2026 23:02:14
• Arbitral Tribunal allowed company's application to rectify computational and clerical errors in the award dated May 14, 2026. • Upward revision of loss of pr…
12-Jun-2026 19:06:12
Maintains a Neutral rating; Raises target price to ₹400 from ₹385 Targets FY31 revenue of ₹55,000 million Implies ~18% annual growth from FY26 levels Growth to…
12-Jun-2026 19:06:12
O-P, TP Rs 462 Analyst day takeaways, Expects FY31 sales to be over Rs55bn with an over 15% Ebitda margin implying a 18% and 28% Cagrs over FY26-31CL. Honasa’s…
12-Jun-2026 19:06:12
Buy, TP Rs 585 Analyst day takeaways, Honasa 2.0 sharpens its growth agenda through AI-led execution, deeper product segmentation, wider distribution and a con…
12-Jun-2026 19:06:10
UPGRADE HOLD TARGET PRICE: (Raised To) ₹384 Upgraded After Analyst Day Guidance FY26-31 Revenue/EBITDA CAGR Guided At 18%/28% EBITDA Margin Targeted To Rise 50…